China-based gene sequencing specialist, MGI Tech Co., Ltd, (SHA: 688114) has announced a commercial collaboration with the Human Cell Atlas (HCA) consortium, marking a significant step forward in the human cell mapping initiative. This partnership aims to expand access to MGI’s proprietary products within the HCA network by offering discounted rates to collaborating members, thereby promoting the global adoption of single cell sequencing and spatial transcriptomics technologies.
Expanding Access to Proprietary Products
The collaboration will enable HCA members to gain more access to MGI’s cost-effective and scalable single cell and spatial omics solutions. By providing these solutions at discounted rates, MGI is facilitating the wider adoption of advanced genomic technologies, which are crucial for understanding the complexity of human cells and their roles in health and disease.
Supporting Research and Development
In addition to providing access to its proprietary products, MGI will also support HCA members in experimental design, assay execution, and bioinformatic support when applying MGI’s technologies to their research. This comprehensive support will empower HCA members to leverage the full potential of single cell sequencing and spatial transcriptomics in their scientific endeavors.-Fineline Info & Tech
Leave a Reply